Mycronic provided consolidated net sales guidance for 2020. The Board's assessment is that consolidated net sales for 2020 will be at a level of SEK 4.1 billion, excluding any acquisitions made in 2020. This outlook remains, but the increased uncertainty in the global economy due to COVID-19 should be noted.